Ullmann Wealth Partners Group, LLC Pfizer Inc Transaction History

Ullmann Wealth Partners Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $9,143 - $11,935	-219 Reduced 3.6%	5,867 $0
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $4,419 - $5,395	-101 Reduced 1.63%	6,086 $266,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $19,914 - $23,612	428 Added 7.43%	6,187 $324,000
Q1 2022 Apr 14, 2022	BUY	$45.75 - $56.69 $15,326 - $18,991	335 Added 6.18%	5,759 $298,000
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $8,511 - $12,617	-206 Reduced 3.66%	5,424 $320,000
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $220,977 - $283,864	5,630 New	5,630 $242,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ullmann Wealth Partners Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ullmann Wealth Partners Group, LLC with notifications on news.